Collect. Czech. Chem. Commun. 2004, 69, 476-498
https://doi.org/10.1135/cccc20040476

Monitoring of DNA Adducts in Humans and 32P-Postlabelling Methods. A Review

Marie Stiborováa,*, Martina Rupertováa, Petr Hodeka, Eva Freib and Heinz H. Schmeiserb

a Department of Biochemistry, Faculty of Science, Charles University in Prague, Albertov 2030, 128 40 Prague 2, Czech Republic
b Department of Molecular Toxicology, German Cancer Research Center, Im Neuenheimer Feld 280, 691 20 Heidelberg, Germany

References

1. Randerath K., Randerath E.: Drug Metab. Rev. 1994, 26, 67. <https://doi.org/10.3109/03602539409029785>
2. Miller E. C., Miller J. A.: Cancer 1981, 47, 1055. <https://doi.org/10.1002/1097-0142(19810301)47:5+<1055::AID-CNCR2820471302>3.0.CO;2-3>
3. Hemminki K.: Carcinogenesis 1993, 14, 2007. <https://doi.org/10.1093/carcin/14.10.2007>
4. Hemminki K., Dipple A., Shuker D. E. G., Kadlubar F. F., Segerback D., Bartsch H.: DNA Adducts: Identification and Biological Significance. IARC Scientific Publications No. 125, IARC, Lyon 1994.
5. Lutz W. K.: J. Cancer Res. Clin. Oncol. 1986, 112, 85. <https://doi.org/10.1007/BF00404387>
6. Otteneder M., Lutz W. K.: Mutat. Res. 1999, 424, 237. <https://doi.org/10.1016/S0027-5107(99)00022-6>
7. Poirier M. C., Santella R. M., Weston A.: Carcinogenesis 2000, 21, 353. <https://doi.org/10.1093/carcin/21.3.353>
8. Wiencke J. K.: Oncogene 2002, 21, 7376. <https://doi.org/10.1038/sj.onc.1205799>
9. Tang D. L., Phillips D. H., Stampfer M., Mooney L. A., Hsu Y. Z., Cho S., Tsai W. Y., Ma J., Cole K. J., Ni She M., Perera F. P.: Cancer Res. 2001, 61, 6708.
10. Veglia F., Matullo G., Vineis P.: Cancer Epidemiol. Biomarkers Prevent. 2003, 12, 157.
11. Verna L., Whysner J., Williams G. M.: Pharmacol. Therapeut. 1996, 71, 83. <https://doi.org/10.1016/0163-7258(96)00063-0>
12. Poirier M. C., Beland F. A.: Chem. Res. Toxicol. 1992, 5, 749. <https://doi.org/10.1021/tx00030a003>
13. Kensler T. W., Groopman I. D., Wogan G. N. in: Principles of Chemoprevention (B. W. Steward, D. McGregor and P. Kleihues, Eds), p. 237. IARC, Lyon 1996.
14. Poirier M. C. in: Control Mechanisms of Carcinogenesis (J. G. Hengstler and F. Oesch, Eds), p. 193. Thieme, Meissen 1996.
15. Beach A. C., Gupta R. C.: Carcinogenesis 1992, 13, 1053. <https://doi.org/10.1093/carcin/13.7.1053>
16. Li D. H., Wang M. Y., Cheng L., Spitz M. R., Hittelmen W. N., Wei Q. Y.: Cancer Res. 1996, 56, 3638.
17. Perera F. P.: Science 1997, 278, 1068. <https://doi.org/10.1126/science.278.5340.1068>
18. Tang D. L., Rundle A., Warburton D., Santella R. M., Tsai W. Y., Chiamprasert S., Hsu Y. Z., Perera F. P.: Carcinogenesis 1998, 19, 1949. <https://doi.org/10.1093/carcin/19.11.1949>
19. Bartsch H., Rojas M., Alexandrov K., Risch A.: Recent Results Cancer Res. 1998, 154, 86. <https://doi.org/10.1007/978-3-642-46870-4_5>
20. Perera F. P., Weinstein I. B.: Carcinogenesis 2000, 21, 517. <https://doi.org/10.1093/carcin/21.3.517>
21. Rundle A., Tang D. L., Hibshoosh H., Estabrook A., Schnabel F., Cao W. F., Grumet S., Perera F. P.: Carcinogenesis 2000, 21, 1281. <https://doi.org/10.1093/carcin/21.7.1281>
22. Vineis P., Perera F. P.: Int. J. Cancer 2000, 88, 325. <https://doi.org/10.1002/1097-0215(20001101)88:3<325::AID-IJC1>3.0.CO;2-K>
23. Berwick M., Vineis P.: J. Natl. Cancer Inst. 2000, 92, 874. <https://doi.org/10.1093/jnci/92.11.874>
24. Vulimiri S. V., Wu X. F., Baer-Dubowska W., de Andrade M., Detry M., Spitz M. R., di Giovanni J.: Mol. Carcinog. 2000, 27, 34. <https://doi.org/10.1002/(SICI)1098-2744(200001)27:1<34::AID-MC6>3.0.CO;2-G>
25. Peluso M., Airoldi L., Magagnotti C., Fiorini L., Munnia A., Hautefeuille A., Malaveille C., Vineis P.: Carcinogenesis 2000, 21, 183. <https://doi.org/10.1093/carcin/21.2.183>
26. Hemminki K., Koskinen M., Zhao C. Y.: Int. J. Cancer 2001, 92, 923. <https://doi.org/10.1002/ijc.1273>
27. Perera F. P., Vineis P.: Int. J. Cancer 2001, 92, 926. <https://doi.org/10.1002/ijc.1274>
28. Perera F. P., Mooney L. A., Stampfer M., Phillips D. H., Bell D. A., Rundle A., Cho S., Tsai W. Y., Ma J., Blackwood A., Tang D. L.: Carcinogenesis 2002, 23, 1641. <https://doi.org/10.1093/carcin/23.10.1641>
29. Benhamou S., Laplanche A., Guillonneau B., Mejean A., Desgrandchamps F., Schrameck C., Degieux V., Perin F.: Mutagenesis 2003, 18, 445. <https://doi.org/10.1093/mutage/geg020>
30. Yuspa S. H., Poirier M. C.: Adv. Cancer Res. 1988, 50, 25. <https://doi.org/10.1016/S0065-230X(08)60434-0>
31. Bishop J. M.: Cell 1991, 64, 235. <https://doi.org/10.1016/0092-8674(91)90636-D>
32. Hemminki K.: J. Occup. Environ. Med. 1995, 37, 44. <https://doi.org/10.1097/00043764-199501000-00007>
33. Lehman T. A., Harris C. C. in: DNA Adducts: Identification and Biological Significance (K. Hemminki, A. Dipple, D. E. G. Shuker, F. F. Kadlubar, D. Segerback and H. Bartsch, Eds), p. 399. IARC Scientific Publications No. 125, IARC, Lyon 1994.
34. Brash D. E., Ziegler A., Jonason A. S., Simon J. A., Kunala S., Leffell D. J.: J. Invest. Dermatol. Symp. Proc. 1996, 1, 136.
35. Denissenko M. F., Pao A., Tang M. S., Pfeifer G. P.: Science 1996, 274, 430. <https://doi.org/10.1126/science.274.5286.430>
36. Kinzler K. W., Vogelstein B.: Nature 1996, 379, 19. <https://doi.org/10.1038/379019a0>
37. Arlt V. M., Stiborová M., Schmeiser H. H.: Mutagenesis 2002, 17, 265. <https://doi.org/10.1093/mutage/17.4.265>
38. Feng Z. H., Hu W. W., Chen J. X., Pao A., Li H. Y., Rom W., Hung M. C.: J. Natl. Cancer Inst. 2002, 94, 1527. <https://doi.org/10.1093/jnci/94.20.1527>
39. Feng Z. H., Hu W. W., Rom W. N., Beland F. A., Tang M. S. Carcinogenesis 2002, 23, 1721. <https://doi.org/10.1093/carcin/23.10.1721>
40. Povey A. C.: Toxicol. Pathol. 2000, 28, 405. <https://doi.org/10.1177/019262330002800308>
41. Nebert D. W., Negishi M.: Biochem. Pharmacol. 1982, 31, 2311. <https://doi.org/10.1016/0006-2952(82)90523-8>
42. Godschalk R. W. L., Van Schooten F. J., Bartsch H.: J. Biochem. Mol. Biol. 2003, 36, 1. <https://doi.org/10.5483/BMBRep.2003.36.1.001>
43. Harris C. C.: Carcinogenesis 1989, 10, 1563. <https://doi.org/10.1093/carcin/10.9.1563>
44. Santella R. M.: Mutat. Res. 1988, 205, 271. <https://doi.org/10.1016/0165-1218(88)90022-5>
45. van Delft J. H. M., Baan R. A., Roza L.: Crit. Rev. Toxicol. 1998, 28, 477. <https://doi.org/10.1080/10408449891344254>
46. Gupta R. C. in: Postlabelling Methods for Detection of DNA Adducts (D. H. Phillips, M. Castegnaro and H. Bartsch, Eds), p. 11. IARC Scientific Publications No. 124, IARC, Lyon 1993.
47. Stiborová M., Frei E., Bieler C. A., Schmeiser H. H.: Chem. Listy 1998, 92, 661.
48. Phillips D. H.: Mutat. Res. 1997, 378, 1. <https://doi.org/10.1016/S0027-5107(97)00092-4>
49. Phillips D. H., Castegnaro M.: Mutagenesis 1999, 14, 301. <https://doi.org/10.1093/mutage/14.3.301>
50. Poirier M. C.: J. Natl. Cancer Inst. 1981, 67, 515.
51. Muller R., Rajewsky M. F.: J. Cancer Res. Clin. Oncol. 1981, 102, 99. <https://doi.org/10.1007/BF00410662>
52. Strickland P. T., Boyle J. M.: Prog. Nucleic Acid Res. Mol. Biol. 1984, 31, 1. <https://doi.org/10.1016/S0079-6603(08)60374-8>
53. Poirier M. C.: Mutat. Res. 1993, 288, 31. <https://doi.org/10.1016/0027-5107(93)90205-T>
54. Santella R. M.: Proc. Soc. Exp. Biol. Med. 1997, 216, 166. <https://doi.org/10.3181/00379727-216-44166>
55. Weston A.: Mutat. Res. 1993, 288, 19. <https://doi.org/10.1016/0027-5107(93)90204-S>
56. Li M., Hurtubise R. J., Weston A.: Anal. Chem. 1999, 71, 4679. <https://doi.org/10.1021/ac9905726>
57. Randerath K., Reddy M. V., Gupta R. C.: Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 6128. <https://doi.org/10.1073/pnas.78.10.6126>
58. Yamamoto Y., Ames B. N.: Free Radical Biol. Med. 1987, 3, 359. <https://doi.org/10.1016/S0891-5849(87)80048-5>
59. Vasquez H., Seifert W., Strobel H.: J. Chromatogr., B: Biomed. Appl. 2001, 759, 185. <https://doi.org/10.1016/S0378-4347(01)00208-0>
60. Marnett L. J., Burcham P. C.: Chem. Res. Toxicol. 1993, 6, 771. <https://doi.org/10.1021/tx00036a005>
61. Hecht S. S., Carmella S. G., Foiles P. G., Murphy S. E.: Cancer Res. 1994, 54, 1912.
62. Vogel J. S., Turteltaub K. W., Finkel R., Nelson D. E.: Anal. Chem. A 1995, 67, 353. <https://doi.org/10.1021/ac00107a001>
63. Dingley K. H., Curtis K. D., Nowell S., Felton J. S., Lang N. P., Tureltaub K. W.: Cancer Epidemiol. Biomarkers Prevent. 1999, 8, 507.
64. Koc H., Swenberg J. A.: J. Chromatogr., B: Biomed. Appl. 2002, 778, 323. <https://doi.org/10.1016/S1570-0232(02)00135-6>
65. Tretyakova N., Matter B., Jones R., Shallop A.: Biochemistry 2002, 41, 9535. <https://doi.org/10.1021/bi025540i>
66. Schmitz O. J., Worth C. C. T., Stach D., Wiessler M.: Angew. Chem. 2002, 41, 445. <https://doi.org/10.1002/1521-3773(20020201)41:3<445::AID-ANIE445>3.0.CO;2-7>
67. Stach D., Schmitz O. J., Stilgenbauer S., Benner A., Dohner H., Wiessler M., Lyko F.: Nucleic Acids Res. 2003, 31, E2-2. <https://doi.org/10.1093/nar/gng002>
68. De Kok T. M. C. M., Moonen H. J. J., van Delft J., van Schooten F. J.: J. Chromatogr., B: Biomed. Appl. 2002, 778, 345. <https://doi.org/10.1016/S0378-4347(01)00543-6>
69. Hellman B., Vaghef H., Boström B.: Mutat. Res. 1995, 336, 123. <https://doi.org/10.1016/0921-8777(94)00047-A>
70. Hellman B., Vaghef H., Friis L., Edling C.: Int. Arch. Occup. Environ. Health 1997, 69, 185. <https://doi.org/10.1007/s004200050135>
71. Vaghef H., Wisén A. C., Hellman B.: Pharmacol. Toxicol. 1996, 78, 37. <https://doi.org/10.1111/j.1600-0773.1996.tb00177.x>
72. Vaghef H., Nygren P., Edling C., Bergh J., Hellman B.: Mutat. Res. 1997, 395, 127. <https://doi.org/10.1016/S1383-5718(97)00157-5>
73. Vaghef H., Hellman B.: Pharmacol. Toxicol. 1998, 83, 69. <https://doi.org/10.1111/j.1600-0773.1998.tb01446.x>
74. Abt G., Vaghef H., Gebhart E., Dahlgren C. V., Hellman B.: Mutat. Res. 1997, 384, 55. <https://doi.org/10.1016/S0921-8777(97)00013-X>
75. Norwood D.: Anal. Biochem. 1999, 272, 100. <https://doi.org/10.1006/abio.1999.4161>
76. Yang Y., Nair J., Barbin A., Bartsch H.: Carcinogenesis 2000, 21, 777. <https://doi.org/10.1093/carcin/21.4.777>
77. Gupta R. C., Reddy M. V., Randerath K.: Carcinogenesis 1982, 3, 1081. <https://doi.org/10.1093/carcin/3.9.1081>
78. Gupta R. C.: Cancer Res. 1985, 45, 5656.
79. Reddy M. V., Randerath K.: Carcinogenesis 1986, 7, 1543. <https://doi.org/10.1093/carcin/7.9.1543>
80. Binková B.: Chem. Listy 1993, 87, 564.
81. Phillips D. H., Farmer P. B., Beland F. A., Nath R. G., Poirier M. C., Reddy M. V., Turteltaub K. W.: Environ. Mol. Mutagen. 2000, 35, 222. <https://doi.org/10.1002/(SICI)1098-2280(2000)35:3<222::AID-EM9>3.0.CO;2-E>
82. Reddy M. V.: Regul. Toxicol. Pharmacol. 2000, 32, 256. <https://doi.org/10.1006/rtph.2000.1430>
83. Yamazoe Y., Miller D. W., Weis C. C., Dooley K. L., Zenser T. V., Beland F. A., Kadlubar F. F.: Carcinogenesis 1985, 6, 1379. <https://doi.org/10.1093/carcin/6.9.1379>
84. Yamazoe Y., Zenser T. V., Miller D. W., Kadlubar F. F.: Carcinogenesis 1988, 9, 1635. <https://doi.org/10.1093/carcin/9.9.1635>
85. Pfau W., Schmeiser H. H., Wiessler M.: Carcinogenesis 1990, 11, 313. <https://doi.org/10.1093/carcin/11.2.313>
86. Pfau W., Schmeiser H. H., Wiessler M.: Chem. Res. Toxicol. 1991, 4, 581. <https://doi.org/10.1021/tx00023a015>
87. Phillips D. H., Hewer A., White J. N. H., Farmer P. B.: Carcinogenesis 1994, 15, 793. <https://doi.org/10.1093/carcin/15.5.793>
88. Stiborová M., Fernando R. C., Schmeiser H. H., Frei E., Pfau W., Wiessler M.: Carcinogenesis 1994, 15, 1187. <https://doi.org/10.1093/carcin/15.6.1187>
89. Zeisig M., Möller L.: Carcinogenesis 1995, 16, 1. <https://doi.org/10.1093/carcin/16.1.1>
90. Mourato L. L. G., Beland F. A., Marques M. M.: Chem. Res. Toxicol. 1999, 12, 661. <https://doi.org/10.1021/tx990038t>
91. Shibutani S., Suzuki N., Terashima I., Sugarman S. M., Grollman A. P., Pearl M. L.: Chem. Res. Toxicol. 1999, 12, 646. <https://doi.org/10.1021/tx990033w>
92. Shibutani S., Ravindernath A., Suzuki N., Terashima I., Sugarman S. M., Grollman A. P., Pearl M. L.: Carcinogenesis 2000, 21, 1461. <https://doi.org/10.1093/carcin/21.8.1461>
93. Turesky R. J.: Drug Metab. Rev. 2002, 34, 625. <https://doi.org/10.1081/DMR-120005665>
94. Reddy M. V., Gupta R. C., Randerath K.: Anal. Biochem. 1981, 117, 271. <https://doi.org/10.1016/0003-2697(81)90722-3>
95. Terashima I., Suzuki N., Shibutani S.: Chem. Res. Toxicol. 2002, 15, 305. <https://doi.org/10.1021/tx010083c>
96. Reichert W. L., Stein J. E., French B., Goodwin P., Vanarasi U.: Carcinogenesis 1992, 13, 1475. <https://doi.org/10.1093/carcin/13.8.1475>
97. Chang L. W., Hsia S. M. T., Chan P. C., Hsieh L. L.: Annu. Rev. Pharmacol. Toxicol. 1994, 34, 41. <https://doi.org/10.1146/annurev.pa.34.040194.000353>
98. Schmeiser H. H., Bieler C. A., Wiessler M., de Strihou C. V., Cosyns J. P.: Cancer Res. 1996, 56, 2025.
99. Bieler C. A., Stiborová M., Wiessler M., Cosyns J. P., de Strihou C. V., Schmeiser H. H.: Carcinogenesis 1997, 18, 1063. <https://doi.org/10.1093/carcin/18.5.1063>
100. Arlt V. M., Ferluga D., Stiborová M., Pfohl-Leskowicz A., Vukelic M., Ceovic S., Schmeiser H. H., Cosyns J. P.: Int. J. Cancer 2000, 101, 500. <https://doi.org/10.1002/ijc.10602>
101. Gonçalves L. L., Beland F. A., Marques M. M.: Chem. Res. Toxicol. 2001, 14, 165. <https://doi.org/10.1021/tx0002031>
102. Randerath E., Agrawal H. P., Weaver J. A., Bordelon C. B., Randerath K.: Carcinogenesis 1985, 6, 1117. <https://doi.org/10.1093/carcin/6.8.1117>
103. Everson R. B., Randerath E., Santella R. M., Cefalo R. C., Avits T. A., Randerath K.: Science 1986, 231, 57. <https://doi.org/10.1126/science.3941892>
104. Randerath K., Gupta R. C., Van Colen K. L.: Carcinogenesis 1993, 14, 1523. <https://doi.org/10.1093/carcin/14.8.1523>
105. Pfau W., Brocksteadt U., Söhren K. D., Marquardt H.: Carcinogenesis 1994, 15, 877. <https://doi.org/10.1093/carcin/15.5.877>
106. Jones G. D. D., Dickinson L., Lumec J., Routledge M. N.: Carcinogenesis 1999, 20, 503. <https://doi.org/10.1093/carcin/20.3.503>
107. Keith G., Dirheimer G.: Curr. Opin. Biotechnol. 1995, 6, 3. <https://doi.org/10.1016/0958-1669(95)80002-6>
108. Randerath K., Randerath E., Smith C. V., Chang J.: Chem. Res. Toxicol. 1996, 9, 247. <https://doi.org/10.1021/tx950085v>
109. Reddy M. V., Bleicher T., Blackburn G. R., Mackerer E. R.: Carcinogenesis 1990, 11, 1349. <https://doi.org/10.1093/carcin/11.8.1349>
110. Stiborová M., Frei E., Schmeiser H. H., Wiessler M.: Carcinogenesis 1992, 13, 1221. <https://doi.org/10.1093/carcin/13.7.1221>
111. Stiborová M., Frei E., Schmeiser H. H., Wiessler M., Hradec J.: Carcinogenesis 1992, 13, 1657. <https://doi.org/10.1093/carcin/13.9.1657>
112. Stiborová M., Asfaw B., Frei E., Schmeiser H. H., Wiessler M.: Chem. Res. Toxicol. 1995, 8, 489. <https://doi.org/10.1021/tx00046a002>
113. Jones N. J., McGregor A. D., Waters R.: Cancer Res. 1993, 53, 1522.
114. Binková B., Lewtas J., Míšková I., Leníček J., Šrám R.: Carcinogenesis 1995, 16, 1037. <https://doi.org/10.1093/carcin/16.5.1037>
115. Randerath K., Randerath E., Zhou G. D., Supunpong N., He L. Y., McDonald T. J., Donnelly K. C.: Environ. Mol. Mutagen. 1999, 33, 303. <https://doi.org/10.1002/(SICI)1098-2280(1999)33:4<303::AID-EM7>3.0.CO;2-0>
116. Pfau W., Phillips D. H.: J. Chromatogr. 1991, 570, 65. <https://doi.org/10.1016/0378-4347(91)80201-M>
117. Pfau W., Hughes N. C., Grover P. L., Phillips D. H.: Cancer Lett. 1992, 65, 159. <https://doi.org/10.1016/0304-3835(92)90161-N>
118. Pfau W., Brockstedt U., Schulze C., Neurath G., Marquardt H.: Carcinogenesis 1996, 17, 2727. <https://doi.org/10.1093/carcin/17.12.2727>
119. Försti A., Staffas J., Hemminki K.: Carcinogenesis 1994, 15, 2829. <https://doi.org/10.1093/carcin/15.12.2829>
120. Stiborová M., Bieler C. A., Wiessler M., Frei E.: Biochem. Pharmacol. 2001, 62, 1675. <https://doi.org/10.1016/S0006-2952(01)00806-1>
121. Stiborová M., Frei E., Wiessler M., Schmeiser H. H.: Chem. Res. Toxicol. 2001, 14, 1128. <https://doi.org/10.1021/tx010059z>
122. Savela K., King L., Gallander J., Lewtas J.: Carcinogenesis 1995, 16, 2083. <https://doi.org/10.1093/carcin/16.9.2083>
123. Dunn B. P., San R. H. C.: Carcinogenesis 1988, 9, 1055. <https://doi.org/10.1093/carcin/9.6.1055>
124. Schmeiser H. H., Dipple A., Schurdak M. E., Randerath E., Randerath K.: Carcinogenesis 1988, 9, 633. <https://doi.org/10.1093/carcin/9.4.633>
125. Hemminki K., Yang K., Rajaniemi H., Tyndyk M., Likhachev A.: Biomarkers 1997, 2, 341. <https://doi.org/10.1080/135475097231427>
126. Dietrich M. W., Hopkins W. E., Asbury K. J., Ridley W. P.: Chromatographia 1987, 24, 545. <https://doi.org/10.1007/BF02688542>
127. Möller L., Grzybowska E., Zeisig M., Cimander B., Hemminki K., Chorazy M.: Carcinogenesis 1996, 17, 61. <https://doi.org/10.1093/carcin/17.1.61>
128. Carlberg C. E., Möller L., Paakki P., Kantola M., Stockmann H., Purkunen R., Wagner P., Laupert U., Kaha M., Elovaara E., Kirkinen P., Pasanen M.: Biomarkers 2000, 5, 182. <https://doi.org/10.1080/135475000230343>
129. Akkineni L. K., Zeisig M., Baranczewski P., Ekstrom L. G., Möller L.: Arch. Toxicol. 2001, 74, 720. <https://doi.org/10.1007/s002040000172>
130. King M. M., Cuzick J., Jenkins D., Routledge M. N., Garner R. C.: Mutat. Res. 1993, 292, 113. <https://doi.org/10.1016/0165-1161(93)90138-P>
131. Nair J., Barbin A., Guichard Y., Bartsch H.: Carcinogenesis 1995, 16, 613. <https://doi.org/10.1093/carcin/16.3.613>
132. Fernando R. C., Nair J., Barbin A., Miller J. A., Bartsch H.: Carcinogenesis 1996, 17, 1711. <https://doi.org/10.1093/carcin/17.8.1711>
133. Hagenlocher T., Nair J., Becker N., Korfmann A., Bartsch H.: Cancer Epidemiol. Biomarkers Prevent. 2001, 10, 1187.
134. Godschalk R., Nair J., Kliem H. C., Wiessler M., Bouvier G., Bartsch H.: Chem. Res. Toxicol. 2002, 15, 433. <https://doi.org/10.1021/tx015582s>
135. Vodička P., Hemminki K.: Chem.-Biol. Interact. 1991, 77, 39. <https://doi.org/10.1016/0009-2797(91)90004-Q>
136. Stiborová M., Martínek V., Rýdlová H., Hodek P., Frei E.: Cancer Res. 2002, 62, 5678.
137. Vodička P., Vodičková L., Hemminki K.: Carcinogenesis 1993, 14, 2059. <https://doi.org/10.1093/carcin/14.10.2059>
138. Fang J. L., Vaca C. E.: Carcinogenesis 1997, 18, 627. <https://doi.org/10.1093/carcin/18.4.627>
139. Koivisto P., Sorsa M., Pacchierotti F., Peltonen K.: Carcinogenesis 1997, 18, 439. <https://doi.org/10.1093/carcin/18.2.439>
140. Kumar R., Vodička P., Peltonen K., Hemminki K.: Carcinogenesis 1997, 18, 407. <https://doi.org/10.1093/carcin/18.2.407>
141. Stiborová M., Mikšanová M., Havlíček V., Schmeiser H. H., Frei E.: Mutat. Res. 2002, 500, 49. <https://doi.org/10.1016/S0027-5107(01)00295-0>
142. Fukutome K., Ochiai M., Wakabayashi K., Watanabe S., Sugimura T., Nagao M.: Jpn. J. Cancer Res. 1994, 85, 113. <https://doi.org/10.1111/j.1349-7006.1994.tb02068.x>
143. Hemminki K., Koskinen M., Rajaniemi H., Zhao C. Y.: Regul. Toxicol. Pharmacol. 2000, 32, 264. <https://doi.org/10.1006/rtph.2000.1431>
144. Peluso M., Ceppi M., Munnia A., Puntoni R., Parodi S.: Am. J. Epidemiol. 2001, 153, 546. <https://doi.org/10.1093/aje/153.6.546>
145. Besaratinia A., Maas L. M., Brouwer E. M. C., Moonen E. J. C., De Kok T. M. C. M., Wesseling G. J., Loft S., Kleinjans J. C. S., Van Schooten F. J.: Carcinogenesis 2002, 23, 1171. <https://doi.org/10.1093/carcin/23.7.1171>
146. Hemminki K., Rajaniemi H., Lindahl B., Moberger B.: Cancer Res. 1996, 56, 4375.
147. Phillips D. H.: Carcinogenesis 2001, 22, 839. <https://doi.org/10.1093/carcin/22.6.839>
148. Phillips D. H., Castegnaro M. in: Postlabelling Methods for Detection of DNA Adducts (D. H. Phillips, M. Castegnaro and H. Bartsch, Eds), p. 35. IARC Scientific Publications No. 124, IARC, Lyon 1993.
149. Chen L., Devanesan P. D., Higginbotham S., Ariese F., Jankowiak R., Small G. J., Rogan E. G., Cavalieri E. L.: Chem. Res. Toxicol. 1996, 9, 897. <https://doi.org/10.1021/tx960004a>
150. Devanesan P. D., Higginbotham S., Ariese F., Jankowiak R., Suh M., Small G. J., Cavalieri E. L., Rogan E. G.: Chem. Res. Toxicol. 1996, 9, 1113. <https://doi.org/10.1021/tx9600513>
151. Chakravarti D., Mailander P. C., Li K. M., Higginbotham S., Zhang H. L., Gross M. L., Meza J. L., Cavalieri E. L., Rogan E. G.: Oncogene 2001, 20, 7945. <https://doi.org/10.1038/sj.onc.1204969>
152. Weinfeld M., Buchko G. W. in: Postlabelling Methods for Detection of DNA Adducts (D. H. Phillips, M. Castegnaro and H. Bartsch, Eds), p. 95. IARC Scientific Publications No. 124, IARC, Lyon 1993.
153. Vodička P., Bastlová T., Vodičková L., Peterková K., Lambert B., Hemminki K.: Carcinogenesis 1995, 16, 1473. <https://doi.org/10.1093/carcin/16.7.1473>
154. Bykov V. J., Jansen C. T., Hemminki K.: Cancer Epidemiol. Biomarkers Prevent. 1998, 7, 199.
155. Xu G. G., Snellman E., Bykov V. J., Jansen C. T., Hemminki K.: J. Invest. Dermatol. 2000, 114, 628. <https://doi.org/10.1046/j.1523-1747.2000.00943.x>
156. Garner R. C.: Mutat. Res. 1998, 402, 67. <https://doi.org/10.1016/S0027-5107(97)00283-2>
157. Gupta R. C., Van Colen K. L., Putman K. L., Randerath K.: Carcinogenesis 1993, 14, 1517. <https://doi.org/10.1093/carcin/14.8.1517>
158. Arlt V. M., Pfohl-Leszkowicz A.., Cosyns J. P., Schmeiser H. H.: Mutat. Res. 2001, 494, 143. <https://doi.org/10.1016/S1383-5718(01)00188-7>
159. Stiborová M., Šimánek V., Frei E., Hobza P., Ulrichová J.: Chem.-Biol. Interact. 2002, 140, 231. <https://doi.org/10.1016/S0009-2797(02)00038-8>
160. Yang Y. C., Yan J., Churchwell M., Beger R., Chan P. C., Doerge D. R., Fu P. P., Chou M. W.: Chem. Res. Toxicol. 2001, 14, 91. <https://doi.org/10.1021/tx000149o>
161. Yang Y. C., Yan J., Doerge D. R., Chan P. C., Fu P. P., Chou M. W.: Chem. Res. Toxicol. 2001, 14, 91. <https://doi.org/10.1021/tx000149o>
162. Randerath K., Puttman K. L., Randerath E.: Biochem. Biophys. Res. Commun. 1993, 192, 61. <https://doi.org/10.1006/bbrc.1993.1381>
163. Pfohl-Leskowicz A., Grosse Y., Kane A., Creppy E. E., Dirheimer G.: Mutat. Res. 1993, 289, 265. <https://doi.org/10.1016/0027-5107(93)90077-S>
164. Munnia A., Puntoni R., Merlo F., Parodi S., Peluso M.: Environ. Mol. Mutagen. 1999, 34, 52. <https://doi.org/10.1002/(SICI)1098-2280(1999)34:1<52::AID-EM8>3.0.CO;2-A>
165. Phillips D. H., Hewer A., Martin C. N., Garner R. C., King M. M.: Nature 1988, 336, 790. <https://doi.org/10.1038/336790a0>
166. Grzybowska E., Hemminki K., Szeliga J., Chorazy M.: Carcinogenesis 1993, 14, 2523. <https://doi.org/10.1093/carcin/14.12.2523>
167. Vermeulen R., Talaska G., Schumann B., Bos R. P., Rothman N., Kromhout H.: Environ. Mol. Mutagen. 2002, 39, 306. <https://doi.org/10.1002/em.10078>
168. Purewal M., Liehr J. G.: Cancer Chemother. Pharmacol. 1993, 33, 239. <https://doi.org/10.1007/BF00686222>
169. Topinka J., Andrae L. I., Schwarz L. R., Wolff T.: Carcinogenesis 1993, 14, 423. <https://doi.org/10.1093/carcin/14.3.423>
170. Stiborová M., Stiborová-Rupertová M., Bořek-Dohalská L., Wiessler M., Frei E.: Chem. Res. Toxicol. 2003, 16, 37. <https://doi.org/10.1021/tx0200818>
171. Lévay G., Ross U., Bodell W. J.: Carcinogenesis 1993, 14, 2329. <https://doi.org/10.1093/carcin/14.6.1241>
172. Pathak D. N., Roy D.: Mutat. Res. 1993, 286, 309. <https://doi.org/10.1016/0027-5107(93)90196-M>
173. Randerath K., Putman K. L., Osterburg H. H., Johnson S. A., Morgan D. G., Finch C. E.: Mutat. Res. 1993, 295, 11. <https://doi.org/10.1016/0921-8734(93)90007-P>
174. Vulimiri S. V., Zhou G. D., Randerath K., Randerath E.: Mutat. Res. 1998, 422, 297. <https://doi.org/10.1016/S0027-5107(98)00211-5>
175. Brockstedt U., Krajinovic M., Richer C., Mathonnet G., Sinnett D., Pfau W., Labuda D.: Mutat. Res. 2002, 516, 41. <https://doi.org/10.1016/S1383-5718(02)00019-0>
176. Hecht S. S.: Ann. N.Y. Acad. Sci. 1997, 833, 91. <https://doi.org/10.1111/j.1749-6632.1997.tb48596.x>
177. Kensler T. W., Groopman J. D.: J. Cell Biochem. 1997, 255, 85.
178. Santella R. M.: Cancer Epidemiol. Biomarkers Prevent. 1999, 8, 733.
179. Linhart I., Novák J.: Chem. Listy 2002, 96, 276.